• No image available for this medication
    • RITUXAN HYCELA

    • QTY 11.7
    • 1400/11.7
    • VIAL
    • Near  77381

RITUXIMAB; HYALURONIDASE (ri TUX i mab / hye al ur ON i dase) is used to treat non-Hodgkin lymphoma and chronic lymphocytic leukemia. Rituximab is a monoclonal antibody. Hyaluronidase is used to improve the effects of rituximab.


RITUXAN HYCELA Information

En Español En Español

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.